European Growth Leaders 2026

Annual ranking data providerLSEG WorkspaceUsed with permission · acknowledgements

An independent research observatory tracking Europe’s listed growth companies.

By Francesco Castellaneta

← All companies

Annual rank82

Spain · Healthcare

Baviera

Ophthalmology-clinic network providing diagnosis, refractive and cataract procedures, specialist treatments and follow-up care for visual disorders.

+52%revenue growth
FY2022–FY2025
+43%net-income growth
FY2022–FY2025
+225%stock return
FY2022–FY2025
+6%2026 stock return
current context only

Company profile · 2026 edition

Eye-care pathways, country brands and a shared clinical platform

At 30 June 2026, Baviera was a listed specialist eye-care group operating 156 clinics across Spain, Germany, Austria, Italy and the United Kingdom. Three local brands—Baviera, CARE Vision and Optimax—combine laser refractive surgery, intraocular-lens procedures and broader ophthalmology. The network uses smaller consultation and follow-up sites alongside surgical clinics that share equipment, staff and management, supported by doctor training, common protocols and brand-level research.

2026 edition record. This historical profile was prepared for the 2026 edition and can include developments after FY2025. Dated plans retain their stated status. Later editions may add analysis; factual corrections and link maintenance remain possible.

Laser and lens procedures

One specialist network, several routes beyond glasses

Across the group, corneal-laser options include LASIK, LASEK and Trans-PRK, while lens routes include phakic ICLs and multifocal or monofocal replacements for higher prescriptions, presbyopia and cataracts. Assessment maps prescription, corneal anatomy and eye health before a clinician recommends a route; the offer is specialist surgery, not a single standard product.

Brands and geography

Three patient-facing names across five countries

At 30 June 2026 the group reported 156 clinics after eight H1 openings: 92 in Spain, 34 in Germany including Vienna, 19 in the United Kingdom and 11 in Italy. Baviera anchors Spain and Italy, CARE Vision serves German-speaking markets, and Optimax adds a British network. These are three patient-facing brands across five countries and four reporting regions, all belonging to one ophthalmology platform.

Medical quality and learning

Protocols travel with research, training and named doctors

CARE Vision's R&D team reviews techniques for common protocols, supported by a central medical committee, a European Medical Advisory Board and cooperation with Hamburg-Eppendorf. The wider group uses Baviera Academy, mentoring and competency checks; Optimax publishes its surgeons and treatment technology so readers can inspect the clinical teams and equipment behind the brand.

Network organisation

Assessment sites feed shared surgical capacity

The group distinguishes satellite clinics—patient acquisition, pre-operative assessment and follow-up—from surgical clinics with specialised equipment. Management units share people, assets and operational leadership across nearby sites; local contact centres use common scheduling and quality controls. Optimax's founder was also its first patient, an unusual origin for a treatment concept that later became part of a multi-country platform.

Annual record

Ranking history

Future editions add rows; they do not rewrite the 2026 record.

EditionMeasurement periodRankRevenue growthNet-income growthStock return
2026FY2022–FY202582+52%+43%+225%